Matches in Nanopublications for { ?s ?p "studies show a cancer-specific loss or suppression of DEFB1 expression in 82% of malignant prostate samples and 90% of renal clear cell carcinomas (5)...WhenDEFB1 is reintroduced to prostate, renal, and bladder cancer cell lines, proliferation is inhibited and apoptosis is induced (5, 6)." ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- _3 value "studies show a cancer-specific loss or suppression of DEFB1 expression in 82% of malignant prostate samples and 90% of renal clear cell carcinomas (5)...WhenDEFB1 is reintroduced to prostate, renal, and bladder cancer cell lines, proliferation is inhibited and apoptosis is induced (5, 6)." provenance.
- _3 value "studies show a cancer-specific loss or suppression of DEFB1 expression in 82% of malignant prostate samples and 90% of renal clear cell carcinomas (5)...WhenDEFB1 is reintroduced to prostate, renal, and bladder cancer cell lines, proliferation is inhibited and apoptosis is induced (5, 6)." provenance.
- _3 value "studies show a cancer-specific loss or suppression of DEFB1 expression in 82% of malignant prostate samples and 90% of renal clear cell carcinomas (5)...WhenDEFB1 is reintroduced to prostate, renal, and bladder cancer cell lines, proliferation is inhibited and apoptosis is induced (5, 6)." provenance.
- _3 value "studies show a cancer-specific loss or suppression of DEFB1 expression in 82% of malignant prostate samples and 90% of renal clear cell carcinomas (5)...WhenDEFB1 is reintroduced to prostate, renal, and bladder cancer cell lines, proliferation is inhibited and apoptosis is induced (5, 6)." provenance.
- _3 value "studies show a cancer-specific loss or suppression of DEFB1 expression in 82% of malignant prostate samples and 90% of renal clear cell carcinomas (5)...WhenDEFB1 is reintroduced to prostate, renal, and bladder cancer cell lines, proliferation is inhibited and apoptosis is induced (5, 6)." provenance.
- _3 value "studies show a cancer-specific loss or suppression of DEFB1 expression in 82% of malignant prostate samples and 90% of renal clear cell carcinomas (5)...WhenDEFB1 is reintroduced to prostate, renal, and bladder cancer cell lines, proliferation is inhibited and apoptosis is induced (5, 6)." provenance.